INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 124 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $126,000 | -43.0% | 27,351 | +24.7% | 0.00% | – |
| Q3 2018 | $221,000 | +54.5% | 21,940 | +10.7% | 0.00% | – |
| Q2 2018 | $143,000 | +21.2% | 19,811 | +1.6% | 0.00% | – |
| Q1 2018 | $118,000 | -30.6% | 19,493 | +10.3% | 0.00% | – |
| Q4 2017 | $170,000 | -60.1% | 17,678 | -47.6% | 0.00% | -100.0% |
| Q2 2017 | $426,000 | +57.8% | 33,712 | +31.1% | 0.00% | – |
| Q1 2017 | $270,000 | +53.4% | 25,712 | +34.5% | 0.00% | – |
| Q4 2016 | $176,000 | +20.5% | 19,112 | +54.2% | 0.00% | – |
| Q3 2016 | $146,000 | -25.9% | 12,394 | -18.4% | 0.00% | – |
| Q2 2016 | $197,000 | -4.4% | 15,197 | +18.1% | 0.00% | – |
| Q1 2016 | $206,000 | -83.1% | 12,869 | -69.7% | 0.00% | -100.0% |
| Q4 2015 | $1,216,000 | – | 42,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
| Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
| JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
| Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
| 12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
| Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
| Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
| Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
| Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |